AllFreePapers.com - All Free Papers and Essays for All Students
Search

Pfizer Information Systems Strategy Triangle

Autor:   •  November 4, 2015  •  Case Study  •  393 Words (2 Pages)  •  1,370 Views

Page 1 of 2

Week 7 – Pfizer Information Systems Strategy Triangle

[pic 1][pic 2][pic 3][pic 4][pic 5]

Business Strategy Elements

Organizational Strategy Elements

Information Strategy Elements

To continue to lead the pharmaceutical industry by implementing products and services using state- of-the art technology

Reduce cost to keep budget under control after the patents expire.

Continue with the implementation of loyalty discount cards in emerging markets.

Continue to utilize technology to gain competitive advantage

Improve mobile applications to keep customer up-to-date in prescriptions and other health related topics

Recognize and classify IT as an strategic asset

Implement a CRM system for physicians.

Impacts between the elements:

For many years Pfizer has been the only manufacturer and distributor of key medications to treat illness such as diabetes, erectile dysfunction and many others. The company’s exclusivity is set to expire in a couple of years. The organization has been looking for ways to continue to lead the pharmaceutical industry without depending on “supper pills” to generate profits. The company has cut more than  46,000 jobs and reduced cost in operations, research and other areas. However, Pfizer’s CEO understands that IT is an strategic asset. Management’s plans are to continue to utilize information technology to gain a competitive advantage. The company started to implement discount cards to track customers’ buying patterns. They are also looking to implement a mobile application to help customers keep track of their medications. The company has also targeted physicians. They are developing a state-of-the-art CRM system to help them operate efficiently, and to provide them with up-to-date patient information.  

...

Download as:   txt (2.9 Kb)   pdf (101.1 Kb)   docx (10.4 Kb)  
Continue for 1 more page »